When the human organism, due to a genetic defect, is unable to correctly metabolize certain types of fatty substances, we are dealing with a congenital lipid metabolism disorder.
The early diagnosis of some of these conditions, classified as rare diseases, has recently been improved following the introduction in Italy of the extended screening of the neonatal population.
PIAM, always attentive to the particular needs of patients with rare or low-prevalence diseases, is able to offer nutritional support therapies for people suffering from certain disorders of lipid metabolism.